GPs (raloxifene)

GPs (raloxifene) is used for the treatment and prevention of osteoporosis compared to the period after menopause in women.

The recommended dose is one tablet of 60 mg daily GPs can be administered at any time without regard to food.

GPs (raloxifene hydrochloride) is a selective modulator of estrogen receptors (SERM) that belongs to the benzothiophene class of compounds. Raloxifene biological actions are largely mediated through binding to estrogen receptors. This leads to the activation of certain mandatory estrogenic pathways and blockade of others. Sun raloxifene, selective modulator of estrogen receptor (SERMs) is.

Raloxifene decreases bone resorption and decreased biochemical markers of bone metabolism, the range of premenopausal. These effects on bone are manifested as reductions in serum and urine markers of bone turnover, decreased bone calcium kinetic studies in radio, increased bone mineral density (BMD) and reduce the incidence of fractures. Raloxifene also has effects on lipid metabolism. Raloxifene reduces total and LDL cholesterol do not increase, but the triglycerides. It does not change the total levels of HDL cholesterol. Preclinical data show that raloxifene is an antagonist of estrogen in the uterus and breast tissue. Data from clinical trials (for a median of 42 months) suggest that raloxifene has no effect on estrogen-like uterine and breast tissues.

If you miss a dose of GPs, skip the missed dose and go back to your regular schedule. Do not take 2 doses at once.

GPs Store at 77 degrees F (25 degrees C) in a tightly closed container. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture and light. Not in the bathroom. GPs kept out of reach of children and pets.

GPs is cons-indicated in women who are nursing or women who are or may be pregnant. It can cause fetal harm when administered to pregnant. GPs is also active in women with past-cons or VTE, including deep vein thrombosis, pulmonary embolism and retinal vein thrombosis in women known to be hypersensitive to raloxifene or other constituents of the tablets.

Venous thromboembolism
In clinical trials, women treated with raloxifene had an increased risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism). Other venous thromboembolic events may also occur. A less serious cases, superficial thrombophlebitis was also reported more frequently with raloxifene. The greatest risk of deep vein thrombosis and pulmonary embolism occurs in the first 4 months of treatment, and the degree of risk appears to be similar to that associated with the risk of using HRT. Because immobilization increases the risk of venous thromboembolic events independent of therapy, GPs at least 72 hours before and during prolonged immobilization (eg, postoperative recovery, prolonged bed rest) should be discontinued, and GPs therapy should be resumed after the patient is fully ambulatory. In addition, women are GPs should be informed to move on a regular basis over a longer trip. The risk-benefit assessment, superficial thrombophlebitis, and malignancy should be considered in women at risk of thromboembolic disease for other reasons such as heart failure.

Endometrium
GPs were not associated with endometrial proliferation up. Unexplained uterine bleeding should be considered as clinically indicated.

Breast
GPs not to breast augmentation, a pain in the chest, or an increased risk of breast cancer. Any unexplained breast abnormality that should be considered during treatment GPs.

History of Breast Cancer
GPs were not sufficiently studied in women with a history of breast cancer.

Renal
Since negligible amounts of raloxifene and excreted in the urine, a study in patients with renal impairment has not been achieved. In the osteoporosis treatment and prevention trials, raloxifene, and metabolite concentrations in women with an estimated creatinine clearance as low as 21 ml / min are similar for women with normal creatinine clearance.

hepatic dysfunction
Raloxifene has been studied in a single dose in the Child-Pugh class A patients with cirrhosis of the liver and total bilirubin between 0.6 to 2.0 mg / dL. raloxifene plasma concentrations were about 2.5 times higher than in controls and correlated with the concentration of bilirubin. The safety and efficacy have not been studied most in patients with hepatic impairment (see Warnings).

Pregnancy
Pregnancy Category X - GPs should not women, or might become pregnant may be used.

Lactation
GPs should not be used by lactating women. It is not known whether raloxifene is excreted in breast milk.

Pediatric Use
GPs should not be used in pediatric patients.

Use in elderly patients
In the trial of treatment of osteoporosis 7705 4621 postmenopausal women were women and elderly (over 65). Of these 845 women over 75 years. Safety and efficacy in older and younger postmenopausal women in the trial treatment of osteoporosis appears to be comparable.

Use in men
The safety and efficacy have not been evaluated in men.

The safety of raloxifene in the treatment of osteoporosis in a large (7705 patients) multinational, placebo-controlled evaluation. Common side effects, as it should be associated with raloxifene hot flashes and leg cramps. The majority of adverse events during the study were generally mild and do not require discontinuation of treatment. These side effects including infections, headaches, nausea, muscle aches, insomnia, rashes, conjunctivitis, vaginitis.

Incidents of overdose in humans have not been reported. In an 8-week study of 63 postmenopausal women with a dose of raloxifene hydrochloride 600 mg / day was well tolerated. No mortality after a single oral dose in rats and mice at 5000 mg / mg / kg (810 times the human dose for rats and 405 times the human dose for mice of the area, mg / m 2) or in monkeys given 1000 / kg (80 times the AUC in humans). There is no specific antidote for raloxifene.

Vitamin A & D

Vitamin A & D prevent fracture and osteoporotic bone loss:

• Vitamin A combinations are used to prevent or treat a calcium deficiency;
• The vitamin D combinations are responsible for cell division and growth of bones.

With vitamin A and D as directed by your doctor. Check the label on the medicine for exact dosing.

• Take Vitamin A and D by mouth with or without food.
• Swallow while vitamin A and D. Do not break, crush or chew before swallowing.
• Several days may pass before your symptoms improve. Do not stop, vitamin A and D without consulting your doctor.
• Take your dose at the same time each day.
• Next to Vitamin A & D, even if you feel comfortable. Do not miss doses.

• Vitamin A is found in foods of animal origin and necessary for cell division, growth of bone, skin, and male and female genitalia and night vision. In pregnant women vitamin A is essential for the growth of a healthy fetus.
• Vitamin D is important for calcium absorption from the stomach and the functioning of calcium in the body.

Take the missed dose as soon as you remember. However, it is almost time for your next dose, skip the missed dose and take only your next scheduled dose. Do not take a double dose of this medication unless your doctor decides otherwise.

Store Vitamin A and D at 77 degrees F (25 degrees C). Brief storage between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture and light. Not in the bathroom. Keep Vitamin A & D out of the reach of children and animals.

Do not use vitamin A and D, if:

• If you use other drugs, do not take Vitamin A & D combination without first talking to your doctor;
• You are allergic to vitamin A and D;

Consult your doctor if any side effects most commonly persist or become bothersome:

• Fatigue, nausea, vomiting, loss of appetite, irritability, headaches, chapped lips or dry skin or hair loss.

In addition, vitamin A and D in the body for growth, good vision and healthy skin is necessary.

Calcium carbonate

Calcium is a mineral used to treat osteoporosis (osteoporosis), treatment of kidney stones, and menstrual discomfort. It is also used as a vitamin supplement to increase bone mass and gastric acid antacids (to disrupt the treatment is used).

With calcium carbonate as directed by your doctor:

• If this medicine without a prescription, follow the instructions on the prescription label. Ask your pharmacist or health care provider if you are not sure how much calcium you should one day.
• Most of the calcium must be taken with meals. Drink a glass of water (8 ounces) with each dose when you are on dialysis.
• If more than one dose a day, take each dose at evenly spaced times, unless your doctor has told you otherwise.

Calcium carbonate provides your body with calcium that your body needs to function properly.

Take the missed dose 100% Pure Coral Calcium Okinawa as soon as you remember. Skip the missed dose and take the medicine at the next scheduled time. Do not take extra medicine to make the missed dose.

Store calcium carbonate at 77 degrees F (25 degrees C). Store away from heat, moisture and light. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Not in the bathroom. Keep Calcium Carbonate out of the reach of children and animals.

Do not use calcium carbonate if you are allergic to any ingredient in calcium carbonate.

Make sure your doctor knows if you are pregnant or breastfeeding, or if you are allergic to shellfish. Tell your doctor if you have kidney disease or have had kidney stones.

Some health problems can affect the amount of calcium you should take. Tell your doctor if you have stomach or digestive problems that are continuing diarrhea, not absorbing nutrients properly, or not enough acid in the stomach.

If you are a large amount of calcium or using for a long time, your doctor may check your blood at regular intervals. Make sure to keep all appointments.

If your doctor has prescribed you remember this drug because he or she has judged that the benefit to you is greater than the risk of side effects. Many people with this drug have no serious side effects.

Tell your doctor immediately if any of these serious side effects, but unlikely:

• Nausea and vomiting;
• Loss of appetite;
• unusual weight loss;
• mental changes in mood /;
• bone pain, muscle;
• Headache;
• increased thirst / urination;
• Weakness;
• unusual tiredness
  
  A very serious allergic reaction to this drug are rare. However, seek immediate medical attention if you experience symptoms of a serious allergic reaction, including the statement:
  
  • Eruption
  • Itching / swelling (especially of face / tongue / throat)
  • severe dizziness
  • Breathlessness
  
  This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
  More
  
  
  • We guarantee our coral calcium to the freshness and the purest available and we return with a guarantee of full reimbursement of 30 days.
  • Contains 74 ionic minerals, pure and organic.
  • Is this positive for alkaline pH balance.
  • Absolutely NO dihydrotriazine dicyandiamide or derivatives.
  • Produced by environmentally friendly over coral.